Evidence map›Paper›PMID 42137798›Full record

ArticleFrontiers in microbiology2026

Rapid and high-sensitivity quantitative fluorescent immunoassay for detection of

Menglu Mao, Keke Li, Chenyao Lin, Xuedan Qiu, Zhen Zhang, Dumei Ma, Qingcao Li

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Menglu Mao *Department of Clinical Laboratory, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.
Keke Li *Genobio Pharmaceutical Co., Ltd., Tianjin, China.
Chenyao LinDepartment of Clinical Laboratory, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.
Xuedan QiuDepartment of Clinical Laboratory, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.
Zhen ZhangSchool of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China.
Dumei MaKey Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Institute of Mass Spectrometry, Ningbo University, Ningbo, China.
Qingcao LiDepartment of Clinical Laboratory, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Early and precise identification of Methods: The assay employs a sandwich immunoassay format, which utilizes carboxylated magnetic agarose microspheres for capture and time-resolved fluorescent microspheres for detection. It enables quantification of the KPC protein within approximately 1 h. The analytical performance of the assay was systematically evaluated, including its sensitivity, linear range, specificity and accuracy. Results: Under optimal experimental conditions, it exhibits a wide linear range (0.25-1000 ng/mL) and a low detection limit of 0.194 ng/mL, and shows no cross-reactivity with other common carbapenemases. Recovery rates in bacterial lysates ranged from 96.7 to 108.4%. Compared to a commercial immunochromatographic test, this method demonstrated superior sensitivity. Discussion: The primary advantage of this fluorescent immunoassay is its ability to achieve rapid, sensitive and quantitative detection of KPC, which addresses a key limitation of current qualitative methods. Its wide linear range and low detection limit enable precise monitoring of KPC expression level variations, offering a novel tool for the clinical assessment of bacterial resistance burden.

Indexed as

fluorescent immunoassayfluoroimmunoassayKlebsiella pneumoniae carbapenemasequantificationquantitative detectionrapid detection

Identifiers

PMID42137798
PMCPMC13170100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.